 oncoGenex Pharmaceuticals (OGXI ) reports third quarter 2015 financial results and provides an update on our clinical programs including our lead product candidate, Custirsen and our second product candidate, Apatorsen.    
 # 1_#1 _ # 1_#1 _ =    # 1 1.25 in.125 in.25 in 